Wet AMD can be successfully treated using vascular endothelial growth factor (VEGF) inhibitors; however, most treated patients have visual impairment due to severe alterations in the retinal tissue, such as fibrosis and/or atrophy [9]. The gene discussed is VEGFA; the disease is age-related macular degeneration.